| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BMS-536924 | CTRPv2 | pan-cancer | AAC | -0.0063 | 0.9 |
| mRNA | tigecycline | CTRPv2 | pan-cancer | AAC | 0.0083 | 0.9 |
| mRNA | JQ12 | GDSC1000 | pan-cancer | AAC | 0.0061 | 0.9 |
| mRNA | ibrutinib | CTRPv2 | pan-cancer | AAC | -0.0069 | 0.9 |
| mRNA | Vandetanib | CCLE | pan-cancer | AAC | 0.0073 | 0.9 |
| mRNA | CCT007093 | GDSC1000 | pan-cancer | AAC | 0.0057 | 0.9 |
| mRNA | WZ8040 | CTRPv2 | pan-cancer | AAC | -0.0061 | 0.9 |
| mRNA | BRD-K02492147 | CTRPv2 | pan-cancer | AAC | -0.0062 | 0.9 |
| mRNA | SMER-3 | CTRPv2 | pan-cancer | AAC | 0.0059 | 0.9 |
| mRNA | PI-103 | CTRPv2 | pan-cancer | AAC | 0.0052 | 0.9 |